JMVPX
Price
$30.04
Change
+$0.01 (+0.03%)
Updated
Dec 26 closing price
Net Assets
11.56B
JVMCX
Price
$26.00
Change
+$0.04 (+0.15%)
Updated
Dec 26 closing price
Net Assets
23.95B
Interact to see
Advertisement

JMVPX vs JVMCX

Header iconJMVPX vs JVMCX Comparison
Open Charts JMVPX vs JVMCXBanner chart's image
JPMorgan Mid Cap Value R3
Price$30.04
Change+$0.01 (+0.03%)
VolumeN/A
Net Assets11.56B
JHancock Disciplined Value Mid Cap C
Price$26.00
Change+$0.04 (+0.15%)
VolumeN/A
Net Assets23.95B
JMVPX vs JVMCX Comparison Chart in %
View a ticker or compare two or three
VS
JMVPX vs. JVMCX commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMVPX is a Hold and JVMCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 23.9B vs. JMVPX (11.6B). JMVPX pays higher dividends than JVMCX: JMVPX (0.62) vs JVMCX (0.00). JMVPX was incepted earlier than JVMCX: JMVPX (9 years) vs JVMCX (14 years). JVMCX (1.86) is less costly to investors than JMVPX (1.20). JVMCX is a more actively managed with annual turnover of: 49.00 vs. JMVPX (39.00). JMVPX has a lower initial minimum investment than JVMCX: JMVPX (0) vs JVMCX (1000). JVMCX annual gain was more profitable for investors over the last year : 1.52 vs. JMVPX (-14.51). JVMCX return over 5 years is better than : 17.72 vs. JMVPX (-12.93).
JMVPXJVMCXJMVPX / JVMCX
Total Expense Ratio1.101.8559%
Annual Report Gross Expense Ratio1.201.8665%
Fund Existence9 years14 years-
Gain YTD-13.3042.767-481%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets11.6B23.9B49%
Annual Yield % from dividends0.620.00-
Returns for 1 year-14.511.52-953%
Returns for 3 years-6.8012.13-56%
Returns for 5 years-12.9317.72-73%
Returns for 10 yearsN/A36.94-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DRTCX20.040.01
+0.05%
BNY Mellon Sust US Equity I
PCAQX86.180.03
+0.03%
Principal Capital Appreciation R5
REQSX21.54N/A
N/A
Russell Inv Equity Income C
FMFMX16.21N/A
N/A
Fidelity Advisor Series Equity Gr
RGEBX77.54N/A
N/A
American Funds Growth Fund of Amer R2E